107 related articles for article (PubMed ID: 14158958)
1. PALLIATIVE MANAGEMENT OF GASTROINTESTINAL CANCER.
HART GD
Can Med Assoc J; 1964 May; 90(22):1265-8. PubMed ID: 14158958
[TBL] [Abstract][Full Text] [Related]
2. TREATMENT OF MALIGNANT NEOPLASMS OF THE GASTROINTESTINAL TRACT WITH A COMBINATION OF 5-FLUOROURACIL AND RADIATION: A RANDOMIZED DOUBLE-BLIND STUDY.
CHILDS DS; MOERTEL CG; HOLBROOK MA; REITEMEIER RJ; COLBY MY
Radiology; 1965 May; 84():843-8. PubMed ID: 14282693
[No Abstract] [Full Text] [Related]
3. THE TREATMENT OF RECURRENT OR METASTATIC BREAST CANCER.
DODSON L; GRANT RN
CA Cancer J Clin; 1963; 13():202-7. PubMed ID: 14054220
[No Abstract] [Full Text] [Related]
4. REGRESSION OF METASTATIC HEPATOMEGALY FROM MAMMARY CARCINOMA. CYTOTOXIC COMBINATION CHEMOTHERAPY WITH 5-FU.
GREENSPAN EM
N Y State J Med; 1964 Oct; 64():2442-9. PubMed ID: 14209557
[No Abstract] [Full Text] [Related]
5. Toxicity data for preoperative concurrent chemoradiotherapy with oxaliplatin and continuous infusion 5-fluorouracil for locally advanced esophageal cancer.
Thukral A; Metz J; Hwang WT; O'Dwyer P; Plastaras J; Both S; Bar-Ad V
Dis Esophagus; 2011 Jul; 24(5):330-6. PubMed ID: 21143694
[TBL] [Abstract][Full Text] [Related]
6. Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes.
McNamara MJ; Adelstein DJ; Allende DS; Bodmann JW; Ives DI; Murthy SC; Raymond D; Raja S; Rodriguez CP; Sohal D; Stephans KL; Videtic GMM; Rybicki LA
J Gastrointest Cancer; 2017 Jun; 48(2):181-189. PubMed ID: 27734205
[TBL] [Abstract][Full Text] [Related]
7. Controlled phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil versus 5-fluorouracil alone in metastatic gastric and rectosigmoid cancer.
Kolarić K; Potrebica V; Stanovnik M
Oncology; 1986; 43(2):73-7. PubMed ID: 3513075
[TBL] [Abstract][Full Text] [Related]
8. THE TREATMENT OF INCURABLE MALIGNANT DISEASE.
HARMAN JB
Nurs Times; 1964 Jun; 60():834-6. PubMed ID: 14172501
[No Abstract] [Full Text] [Related]
9. [EVALUATION OF ADJUVANT POSTOPERATIVE CHEMOTHERAPY AND RADIATION THERAPY IN GASTRIC CANCER].
KIKUCHI K; ANEHA Y; YAMANAKA M; TANEICHI T; NATSUME R; KANNO H; NAGANUMA H; SATO Y; YOSHIZUMI M; KUNII Y; SATO T; YAMAGATA S; WATANABE R
Gan No Rinsho; 1964 Nov; 10():800-5. PubMed ID: 14253637
[No Abstract] [Full Text] [Related]
10. DRUGS USED WITH RADIATION IN THE TREATMENT OF CANCER.
HODNETT EM
Cancer Chemother Rep; 1963 Oct; 32():55-65. PubMed ID: 14088836
[No Abstract] [Full Text] [Related]
11. [ON THE EXPEDICIENCY OF PALLIATIVE STOMACH RESECTION COMBINED WITH CHEMOTHERAPY IN CANCER].
SEMENOV NK
Vopr Onkol; 1964; 10():74-81. PubMed ID: 14182992
[No Abstract] [Full Text] [Related]
12. [SELECTION OF METHODS OF TREATMENT IN OVARIAN CANCERS].
GARCIA G; ALGORI I; PULIDO I; ALVA F
Ginecol Obstet Mex; 1963; 18():355-72. PubMed ID: 14083086
[No Abstract] [Full Text] [Related]
13. [ANTITUMOR CHEMOTHERAPY IN THE TREATMENT OF MALIGNANT NEOPLASMS OF THE OVARY].
BIANCHI F; CAZZOLA D
Quad Clin Ostet Ginecol; 1964 Feb; 19():50-65. PubMed ID: 14162186
[No Abstract] [Full Text] [Related]
14. COMBINED 5-FLUOROURACIL AND SUPERVOLTAGE RADIATION THERAPY IN THE PALLIATIVE MANAGEMENT OF ADVANCED GASTROINTESTINAL CANCER: A PILOT STUDY.
MOERTEL CG; REITEMEIER RJ; CHILDS DS; COLBY MY; HOLBROOK MA
Mayo Clin Proc; 1964 Oct; 39():767-71. PubMed ID: 14237003
[No Abstract] [Full Text] [Related]
15. [TREATMENT OF BLADDER CARCINOMA. PRESENTATION OF 60 CASES AT THE INSTITUTO NACIONAL DE CANCEROLOG'IA].
HERNANDEZGONZALEZ M
Rev Mex Urol; 1964; 23():211-33. PubMed ID: 14171830
[No Abstract] [Full Text] [Related]
16. (OUR EXPERIENCE IN USING THIOTEPA IN ONCOLOGICAL HOSPITALS.).
KUNDZINYA I; TSEPLITT R; POORKALN T; AUZINYA A
Acta Unio Int Contra Cancrum; 1964; 20():360-2. PubMed ID: 14151929
[No Abstract] [Full Text] [Related]
17. SERIAL ENZYME CHANGES IN CANCER PATIENTS UNDERGOING CHEMOTHERAPY.
KABAKOW B; ALBAUM H; ANTOPOL W; BLINICK G; SUSSMAN L; GINZBURG L
Acta Unio Int Contra Cancrum; 1964; 20():333-6. PubMed ID: 14151922
[No Abstract] [Full Text] [Related]
18. ADJUVANT CHEMOTHERAPY IN CANCER OF THE LARGE BOWEL. AN INTERIM REPORT OF THE VETERANS ADMINISTRATION SURGICAL ADJUVANT CANCER CHEMOTHERAPY STUDY.
DWIGHT RW
Am J Surg; 1964 Apr; 107():609-13. PubMed ID: 14136347
[No Abstract] [Full Text] [Related]
19. METHODOLOGY OF PRELIMINARY CHEMOTHERAPEUTIC TRIALS IN PATIENTS WITH MALIGNANT SOLID TUMORS.
BRINDLEY CO
Cancer Chemother Rep; 1963 Oct; 32():27-33. PubMed ID: 14088833
[No Abstract] [Full Text] [Related]
20. A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites.
Oh SY; Kwon HC; Lee S; Lee DM; Yoo HS; Kim SH; Jang JS; Kim MC; Jeong JS; Kim HJ
Jpn J Clin Oncol; 2007 Dec; 37(12):930-5. PubMed ID: 18211984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
